|
|
 Previous Article | Table of Contents | Next Article 
Stem Cell Factor Enhances Interleukin-2-Mediated Expansion of Murine Natural Killer Cells In Vivo
Todd A. Fehniger,
William E. Carson,
Ewa Mrózek, and
Michael A. Caligiuri
From the Divisions of Medicine, Molecular Immunology, and Surgery, Roswell Park Cancer Institute, Buffalo, NY.
The administration of low dose interleukin-2 (IL-2) results in a selective expansion of natural killer (NK) cells in vivo, and promotes the differentiation of NK cells from hematopoietic precursor cells in vitro. We have previously shown that stem cell factor (SCF ), the ligand to the c-kit tyrosine kinase receptor, enhances IL-2-induced NK cell proliferation and differentiation in vitro. Here, we investigated the effects of SCF plus IL-2 delivered to mice in vivo. Eight-week-old C57BL/6 mice were treated with a continuous subcutaneous infusion of IL-2 (1 × 104 IU/d) plus a daily intraperitoneal dose of SCF (100 µg/kg/d), IL-2 alone, SCF alone, or vehicle alone for 8 weeks. The in vivo serum concentration of IL-2 ranged between 352 ± 12.0 pg/mL and 606 ± 9.0 pg/mL, achieving selective saturation of the high affinity IL-2 receptor, while the peak SCF serum concentration was 296 ± 13.09 ng/mL. Alone, the daily administration of SCF had no effect on the expansion of NK cells. The continuous infusion of IL-2 alone did result in a significant expansion of NK1.1+CD3- cells compared to mice treated with placebo or SCF. However, mice treated with both SCF and IL-2 showed an increase in the absolute number of NK cells that was more than twofold that seen with IL-2 alone, in the spleen (P  .005), bone marrow (P .025), and blood (P < .05). NK cytotoxic activity against YAC-1 target cells was significantly higher for mice treated with SCF plus IL-2, compared to mice treated with IL-2 alone (P .0005). Interferon- (IFN-) production in cytokine-activated splenocytes was also greater for the SCF plus IL-2 group, over IL-2 treatment alone (P .01). The effect of SCF plus IL-2 on NK cell expansion was likely mediated via NK cell precursors, rather than mature NK cells. In summary, we provide the first evidence that SCF can significantly enhance expansion of functional NK cells induced by the prolonged administration of low dose IL-2 in vivo. Since the NK cell is a cytotoxic innate immune effector and a potent source of IFN-, this therapeutic strategy for NK cell expansion may serve to further enhance innate immune surveillance against malignant transformation and infection in the setting of cancer and/or immunodeficiency.
Blood, Vol. 90 No. 9 (November 1), 1997:
pp. 3647-3653
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
D. M. Benson Jr, J. Yu, B. Becknell, M. Wei, A. G. Freud, A. K. Ferketich, R. Trotta, D. Perrotti, R. Briesewitz, and M. A. Caligiuri
Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells
Blood,
March 19, 2009;
113(12):
2706 - 2714.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. H. Shah, A. G. Freud, D. M. Benson Jr., A. K. Ferkitich, B. J. Dezube, Z. P. Bernstein, and M. A. Caligiuri
A Phase I Study of Ultra Low Dose Interleukin-2 and Stem Cell Factor in Patients with HIV Infection or HIV and Cancer.
Clin. Cancer Res.,
July 1, 2006;
12(13):
3993 - 3996.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Shimozato, J. R. Ortaldo, K. L. Komschlies, and H. A. Young
Impaired NK Cell Development in an IFN-{gamma} Transgenic Mouse: Aberrantly Expressed IFN-{gamma} Enhances Hematopoietic Stem Cell Apoptosis and Affects NK Cell Differentiation
J. Immunol.,
February 15, 2002;
168(4):
1746 - 1752.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Andrew and R. Aspinall
IL-7 and Not Stem Cell Factor Reverses Both the Increase in Apoptosis and the Decline in Thymopoiesis Seen in Aged Mice
J. Immunol.,
February 1, 2001;
166(3):
1524 - 1530.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. A. Fehniger and M. A. Caligiuri
Interleukin 15: biology and relevance to human disease
Blood,
January 1, 2001;
97(1):
14 - 32.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. F. Duarte and D. A. Frank
SCF and G-CSF lead to the synergistic induction of proliferation and gene expression through complementary signaling pathways
Blood,
November 15, 2000;
96(10):
3422 - 3430.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Gazitt
Immunologic Profiles of Effector Cells and Peripheral Blood Stem Cells Mobilized with Different Hematopoietic Growth Factors
Stem Cells,
November 1, 2000;
18(6):
390 - 398.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
F. Colucci and J. P. Di Santo
The receptor tyrosine kinase c-kit provides a critical signal for survival, expansion, and maturation of mouse natural killer cells
Blood,
February 1, 2000;
95(3):
984 - 991.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. E. Carson, H. Yu, J. Dierksheide, K. Pfeffer, P. Bouchard, R. Clark, J. Durbin, A. S. Baldwin, J. Peschon, P. R. Johnson, et al.
A Fatal Cytokine-Induced Systemic Inflammatory Response Reveals a Critical Role for NK Cells
J. Immunol.,
April 15, 1999;
162(8):
4943 - 4951.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
